INTRODUCTION
HF continues to be a serious medical problem all over the world, resulting in significant morbidity and mortality despite advancements in therapeutic strategies. Current research indicates the involvement of the gut-heart axis in HF. Gut microbiome metabolites, including TMAO and SCFAs, affect heart struct...
S. Senapati, Debabrata Mukherjee· Cardiovascular & Haematologi...· 0 citations
Current HF management is increasingly phenotype- and trajectory-guided, but its clinical adoption is limited by optimal implementation and access barriers, so future research should focus on outcomes-based validation with a clear patient-selection framework to enable durable real-world implementation to improve outcome...
Lakshmi Kattamuri, Kunal Sharma, Debabrata Mukherjee· International Journal of Ang...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.